Actelion Pharmaceuticals Us, Inc. drugs

6 results

  • opsumit - macitentan tablet, film coated

    (Macitentan)
    Actelion Pharmaceuticals Us, Inc.
    Opsumit treats pulmonary arterial hypertension (PAH, WHO Group I) in adults, reducing the risk of disease progression and hospitalization. Effective in WHO Functional Class II–III patients, including idiopathic, heritable, connective tissue disorder-associated, and congenital heart disease-associated PAH.
    Medication Details
    Drug Interactions

  • tracleer - bosentan tablet, film coated

    (Bosentan)
    Actelion Pharmaceuticals Us, Inc.
    Tracleer treats pulmonary arterial hypertension (PAH) in adults to improve exercise ability and slow disease progression, and in children 3+ years with idiopathic or congenital PAH to reduce pulmonary vascular resistance.
    Medication Details
    Drug Interactions

  • uptravi - selexipag tablet, coated

    (Selexipag)
    Actelion Pharmaceuticals Us, Inc.
    Uptravi treats pulmonary arterial hypertension (PAH, WHO Group I) in adults and children aged 2 and older. It delays disease progression and reduces the risk of hospitalization for PAH.
    Medication Details
    Drug Interactions

  • veletri - epoprostenol injection, powder, lyophilized, for solution

    (Epoprostenol)
    Actelion Pharmaceuticals Us, Inc.
    Veletri treats pulmonary arterial hypertension (PAH, WHO Group 1) to improve exercise capacity, primarily in adults with NYHA Class III–IV symptoms due to idiopathic, heritable, or connective tissue disease-associated PAH.
    Medication Details
    Drug Interactions

  • zavesca - miglustat capsule

    (Miglustat)
    Actelion Pharmaceuticals Us, Inc.
    ZAVESCA is indicated as monotherapy for adults with mild to moderate type 1 Gaucher disease when enzyme replacement therapy is not an option due to allergy, hypersensitivity, or poor venous access.
    Medication Details